Trials / Completed
CompletedNCT05200325
Clinical Utility Evidence for TissueCypher®
Establishing Clinical Utility Evidence to Support Coverage and Reimbursement for TissueCypher®: A CPV® Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 280 (actual)
- Sponsor
- Qure Healthcare, LLC · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Cernostics has developed a new diagnostic test, and this study will measure how gastroenterologists and foregut surgeons make diagnostic and treatment decisions when presented with different information in the context of simulated clinical cases. The results of this study could contribute to improved quality of care for patients by encouraging better care practices and adherence to evidence-based guidance. The data from this study will be provided to all participating physicians and submitted to a national journal for publication. The study plans to enroll up to 249 physicians.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Educational materials for TissueCypher | These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report. |
Timeline
- Start date
- 2021-06-06
- Primary completion
- 2021-12-15
- Completion
- 2021-12-15
- First posted
- 2022-01-20
- Last updated
- 2023-12-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05200325. Inclusion in this directory is not an endorsement.